Market Value782,348,000
Total Holdings42
File Date2016-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
AGTC / Applied Genetic Technologies Corp
VTAE / Vitae Pharmaceuticals, Inc.
KERX / Keryx Biopharmaceuticals, Inc.
SBBP / Strongbridge Biopharma plc
WGBS / WaferGen Bio-Systems, Inc.
PTCT / PTC Therapeutics, Inc.
PATI / Patriot Transportation Holding, Inc.
0HBB / Aimmune Therapeutics Inc
TROV / TrovaGene, Inc.
CHRS / Coherus Oncology, Inc.
/ Array BioPharma, Inc.
SCMP / Sucampo Pharmaceuticals, Inc.
AKBA / Akebia Therapeutics, Inc.
ACOR / Acorda Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
OCRX / Ocera Therapeutics, Inc.
MACK / Merrimack Pharmaceuticals, Inc.
JUNO / Juno Therapeutics, Inc.
ARAV / Aravive, Inc.
SIOX / Sio Gene Therapies Inc.
CNCE / Concert Pharmaceuticals Inc
ZYNE / Zynerba Pharmaceuticals Inc
ALKS / Alkermes plc
COLL / Collegium Pharmaceutical, Inc.
AVXS / AveXis, Inc.
DRNA / Dicerna Pharmaceuticals Inc
SRRA / Sierra Oncology Inc
RGEN / Repligen Corporation
TTOO / T2 Biosystems, Inc.
NDRM / NeuroDerm Ltd.
TSRO / TESARO, Inc.
AMGN / Amgen Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
OMER / Omeros Corporation
CASC / Cascadian Therapeutics, Inc.
OREX / Orexigen Therapeutics, Inc.
AGRX / Agile Therapeutics, Inc.
DMTX / Dimension Therapeutics, Inc.
NTRA / Natera, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
ZSPH / ZS Pharma, Inc.
TENX / Tenax Therapeutics, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation
ACAD / ACADIA Pharmaceuticals Inc.
TRVN / Trevena, Inc.
VXRT / Vaxart, Inc.
LUMO / Lumos Pharma, Inc.
ARDX / Ardelyx, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
TXMD / TherapeuticsMD, Inc.
ABUS / Arbutus Biopharma Corporation
AUPH / Aurinia Pharmaceuticals Inc.
DYAX / Dyax Corp.
RGLS / Regulus Therapeutics Inc.
NVAX / Novavax, Inc.
ABIO / ARCA biopharma, Inc.
DVAX / Dynavax Technologies Corporation
WVE / Wave Life Sciences Ltd.
ARNA / Arena Pharmaceuticals Inc
SGMO / Sangamo Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc. Call
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
ZGNX / Zogenix Inc
GBT / Global Blood Therapeutics Inc.
BBI / Brickell Biotech Inc
BCRX / BioCryst Pharmaceuticals, Inc.
CELG / Celgene Corp.
BIIB / Biogen Inc.
ARMP / Armata Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
ALPN / Alpine Immune Sciences, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
TGTX / TG Therapeutics, Inc.
RMTI / Rockwell Medical, Inc.
LRMR / Larimar Therapeutics, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
DSCI / Derma Sciences, Inc.
NLTX / Neoleukin Therapeutics, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
PBYI / Puma Biotechnology, Inc.
H03579101 / Auris Medical Holding Ltd
CDTX / Cidara Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
NKTR / Nektar Therapeutics